Oral delta-9-tetrahydrocannabinol (THC) increases parasympathetic activity and supraspinal conditioned pain modulation in chronic neuropathic pain male patients: A crossover, double-blind, placebo-controlled trial
Journal
CNS drugs
Publication Date
5-1-2024
Volume
38
Issue
5
First Page
375
Last Page
385
Document Type
Open Access Publication
DOI
10.1007/s40263-024-01085-0
Rights and Permissions
Weizman, L., Sharon, H., Dayan, L. et al. Oral Delta-9-Tetrahydrocannabinol (THC) Increases Parasympathetic Activity and Supraspinal Conditioned Pain Modulation in Chronic Neuropathic Pain Male Patients: A Crossover, Double-Blind, Placebo-Controlled Trial. CNS Drugs 38, 375–385 (2024). https://doi.org/10.1007/s40263-024-01085-0 This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
Recommended Citation
Weizman, Libat; Sharon, Haggai; Dayan, Lior; Espaniol, Joumana; Brill, Silviu; Nahman-Averbuch, Hadas; Hendler, Talma; and Jacob, Giris, "Oral delta-9-tetrahydrocannabinol (THC) increases parasympathetic activity and supraspinal conditioned pain modulation in chronic neuropathic pain male patients: A crossover, double-blind, placebo-controlled trial." CNS drugs. 38, 5. 375 - 385. (2024).
https://digitalcommons.wustl.edu/oa_4/5879
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
